Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

FDA approves new therapy for pancreatic cancer

October 30, 2015 Medical Communications, Sales and Marketing FDA, Pancreatic cancer

The FDA has approved drug a pancreatic cancer drug, Onivyde, which has produced significant overall survival rates in an international …
News

Valeant drops Philidor after prescription fraud row

October 30, 2015 Medical Communications, Sales and Marketing Valeant

Valeant has announced that it is ‘severing all ties with Philidor’, the specialty pharmacy at the heart of recent controversy surrounding …
News

Allergan acquires rights to pioneering IBS treatment from Almirall

October 29, 2015 Medical Communications, Sales and Marketing Allergan, Constella, IBS, linaclotide

Allergan and its commercialisation partner Ironwood Pharmaceuticals have announced that Allergan has acquired the rights to Constella.The companies have acquired …
News

ANALYSIS: The challenges of forecasting biosimilar sales across Europe

October 29, 2015 Manufacturing and Production, Research and Development, Sales and Marketing biologics, biosimilars, generics, patent cliff, patents, sales, sales forecasts

The introduction of biologic medicines revolutionised treatment in several key therapeutic areas, including oncology, diabetes and various inflammatory diseases.The landscape …
Feature

FDA approves Bristol-Myers Squibb’s skin cancer drug

October 29, 2015 Sales and Marketing BMS, Bristol-Myers Squibb, Yervoy, ipilumumab, melanoma

The FDA has recommended Bristol-Myers Squibb’s cancer drug Yervoy (ipilimumab) for the adjuvant treatment of patients with melanoma. The drug, …
News

Novo Nordisk posts strong nine-month results

October 29, 2015 Sales and Marketing Novo Nordisk, insulin

Novo Nordisk has exceeded market expectations in its nine-month financial results, reporting a 51% increase in operating profit and 33% …
News

Bayer posts strong earnings growth

October 29, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

Sales across the Bayer group rose by 1.9% in the third quarter of 2015 to €11 billion, according the company’s …
News

Pfizer in ‘friendly’ merger talks with Allergan

October 29, 2015 Sales and Marketing Actavis, Allergan, Pfizer, Teva

Pfizer is in talks with Allergan over what could be the largest takeover deal in an already record-breaking year, it …
News

Baxter names José Almeida chairman and chief executive

October 29, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Joe Almeida, José Almeida, baxter

Baxter has named José (Joe) Almeida as the company’s new chairman and chief executive from January 1, 2016. Almeida will …
Appointment

FDA approves first-in-class Amgen melanoma drug

October 28, 2015 Research and Development, Sales and Marketing Amgen, Imlygic, melonoma

The US Food and Drug Administration (FDA) has approved Amgen’s Imlygic for the treatment of melanoma lesions in the skin …
News

Otsuka kidney drug earns first NICE nod

October 28, 2015 Research and Development, Sales and Marketing NHS, NICE, jinarc, kidney disease, tolvaptan

NICE has released final guidance recommending Otsuka’s Jinarc, the first-ever treatment shown to slow progression of life-threatening Autosomal Dominant Polycystic …
News

Sales up at MSD while Keytruda hits survival target in late-stage trial

October 28, 2015 Research and Development, Sales and Marketing MSD, Merck, financial results, keytruda, pembrolizumab

Worldwide sales at MSD were $10.1 billion in the third quarter of 2015, a 4% increase after accounting for the …
News

Otsuka, GW announce Sativex fails in Phase III cancer pain trials

October 28, 2015 Research and Development, Sales and Marketing Cancer, GX Pharmaceuticals, Otsuka, Sativex, cancer pain, palliative care, phase III, phase III failure

Otsuka and GW Pharmaceuticals cannabis-based drug Sativex failed to show superiority over placebo in two Phase III trials.The studies were …
News

OPINION: ‘More work remains if biosimilars are to fulfil their potential’

October 27, 2015 Manufacturing and Production, Research and Development, Sales and Marketing British Generic Manufacturers Association, NHS, bgma, biosimilars, generics, patent cliff, patents

Despite having a mature generics market which fulfils more than three-quarters of all prescriptions in the UK, and as a …
Feature

Novartis misses Q3 forecast with $390m settlement payment, strong dollar

October 27, 2015 Manufacturing and Production, Sales and Marketing Alcon, Novartis, Sandoz

Novartis reported lower-than anticipated third quarter earnings on Tuesday, hit by the $390 million settlement it has agreed to pay …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026